Skip to main content

2 February 2023

Last updated: Saturday 28 January 2023

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Commentary: Thought disruption in R&D discovery

Tuesday 27 December 2016

Interviewee/Contributor

Tony Sedgwick

Organisation

Novasecta Ltd

Novacta targets C. difficile the natural way

Wednesday 6 May 2009

Interviewee/Contributor

Tony Sedgwick

Organisation

Novacta Biosystems Ltd

Organisations

Provecs Medical GmbH
Vertex Pharmaceuticals Inc
Immune Targeting Systems Ltd
ReNeuron Group Plc
BC Platforms AG
Genmab A/S
Index Ventures
European Bioinformatics Institute
Cellectis SA
CancerPartnersUK

Interviewees and Contributers

Nessa Carey
David Best
Koenraad Wiedhaup
Désiré Collen
Iain McGill
Gerald Möller
Paige Bischoff
Clare Ozawa
Frank Carr
Iain Wilcock

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Kristof Van Emelen joins Scenic Biotech

Saturday 28 January 2023

Rachel Abbott is CSO at Pan Cancer T

Saturday 28 January 2023

Jonathan Curtain named CFO at Ergomed

Wednesday 25 January 2023

BioSenic appoints CSO

Wednesday 25 January 2023

Faron appoints Maija Hollmén as CSO

Sunday 8 January 2023

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2023 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form